Bipolar Ii Disorder
📧 Sign up to get email alerts when something new happens for Bipolar Ii Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-07-08Clinical Trial Update: Gabapentin for Restoring GABA/Glutamate Homeostasis in Co-occurring Bipolar and Cannabis Use Disorders [Phase 2]
A Phase 2 clinical trial is evaluating gabapentin for restoring GABA/glutamate homeostasis in people with co-occurring bipolar disorder and …
-
CLINICAL_TRIALS withdrawal · 2025-06-05Clinical Trial Update: A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Bipolar Disorder
ProgenaBiome's non-interventional pilot study investigating the role of gut flora in bipolar disorder has been withdrawn.
-
CLINICAL_TRIALS research · 2025-03-28Clinical Trial Update: SYNCED - SYNChronized Eating in Bipolar Depression Study [NA]
A not-yet-recruiting clinical trial named SYNCED is investigating synchronized eating as an intervention for bipolar depression, including B…
-
CLINICAL_TRIALS research · 2025-03-18Clinical Trial Update: A Compassionate-focused Intervention for Older People with Bipolar Disorder [NA]
A clinical trial sponsored by the University of Manchester is evaluating a compassionate-focused intervention for older adults with bipolar …
-
CLINICAL_TRIALS trial_result · 2025-03-17Clinical Trial Update: Efficacy of the Mobile Application for Prediction and Prevention of Mood Episode Recurrence Based on Machine Learning [NA]
A completed clinical trial evaluating the efficacy of a machine-learning-based mobile app to predict and prevent mood episode recurrence in …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-02-18Clinical Trial Update: Phase 2 Clinical Trial of GH001 in Bipolar II Disorder [Phase 2]
A Phase 2 study of GH001 in Bipolar II Disorder has been terminated, ending the trial.
-
CLINICAL_TRIALS research · 2024-12-13Clinical Trial Update: The Bipolar Lithium Imaging Scan Study.
This clinical trial update indicates that the lithium imaging scan study for bipolar disorder I or II is currently recruiting at Leiden Univ…
-
CLINICAL_TRIALS trial_result · 2024-11-18Clinical Trial Update: Synaptic Imaging and Network Activity in Treatment Resistant Depression [NA]
King's College London completed a clinical trial investigating synaptic imaging and network activity in treatment-resistant depression.
-
CLINICAL_TRIALS trial_result · 2024-11-04Clinical Trial Update: Efficacy of Convulsive Therapies for Bipolar Depression [NA]
A completed clinical trial evaluating the efficacy of convulsive therapies for bipolar depression, sponsored by the Centre for Addiction and…
-
CLINICAL_TRIALS research · 2024-09-25Clinical Trial Update: Psilocybin Therapy for Depression in Bipolar II Disorder [Phase 2]
A Phase 2 clinical trial evaluating psilocybin therapy for depression in Bipolar II Disorder is currently active but not recruiting, sponsor…
-
CLINICAL_TRIALS research · 2024-08-07Clinical Trial Update: Light-Therapy in the Treatment of the Acute Phase of the Bipolar Type II Depression [NA]
Clinical trial update on light therapy for the acute depressive phase of Bipolar II Disorder; the study is currently active but not recruiti…
-
CLINICAL_TRIALS trial_result · 2024-06-26Clinical Trial Update: Evaluating the Hypothesized Mechanism of Action of N-acetylcysteine for Bipolar Disorder [Phase 2]
Phase 2 trial evaluating N-acetylcysteine for Bipolar Disorder has completed; results were posted on 2024-06-26.
-
CLINICAL_TRIALS research · 2024-04-30Clinical Trial Update: Accelerated Intermittent Theta-Burst Stimulation (aiTBS) in Treatment-Resistant Depression of Bipolar II Disorder [NA]
Clinical trial evaluating accelerated intermittent theta-burst stimulation as a treatment for treatment-resistant depression in Bipolar II d…
-
FDA approval · 2023-06-07FDA Approved: QUETIAPINE FUMARATE — Supplemental Application (Macleods Pharmaceuticals Limited)
FDA approved a supplemental application for Quetiapine Fumarate by Macleods Pharmaceuticals Limited under ANDA203359.
-
CLINICAL_TRIALS trial_result · 2023-02-22Clinical Trial Update: Differential Responses to Drugs and Sweet Tastes [Phase 1]
Phase 1 clinical trial investigating differential responses to drugs and sweet tastes in Bipolar II Disorder; study completed with results p…
-
CLINICAL_TRIALS trial_result · 2022-10-25Clinical Trial Update: The Safety and Efficacy of Psilocybin in Participants With Type 2 Bipolar Disorder (BP-II) Depression. [Phase 2]
Phase 2 trial update evaluating safety and efficacy of psilocybin for treatment-resistant depression in adults with bipolar II disorder.
-
FDA approval · 2022-04-05FDA Approved: IGALMI — Original Application (BioXcel Therapeutics, Inc.)
FDA approves IGALMI (dexmedetomidine) by BioXcel Therapeutics for the acute treatment of agitation in adults with schizophrenia or bipolar I…
-
CLINICAL_TRIALS research · 2022-03-15Clinical Trial Update: The BIO-K Study: A Single-Arm, Open-Label, Biomarker Development Clinical Trial of Ketamine for Non-Psychotic Unipolar Major Depression and Bipolar I or II Depression. [Phase 4]
A Phase 4 single-arm biomarker development trial evaluating ketamine for non-psychotic unipolar major depression and bipolar depression has …
-
CLINICAL_TRIALS trial_result · 2021-03-09Clinical Trial Update: add-on Low Dose Memantine in Middle-to-old Aged Bipolar II Disorder Patients [Phase 2, Phase 3]
A clinical trial investigating add-on low-dose memantine for bipolar II disorder in middle-to-older adults, spanning Phase 2 and Phase 3.
-
CLINICAL_TRIALS trial_result · 2020-11-13Clinical Trial Update: Gabapentin for Bipolar & Cannabis Use Disorders [Phase 2]
Phase 2 clinical trial investigating gabapentin for bipolar disorder and cannabis use disorders has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-08-14Clinical Trial Update: Sequential Multiple Assignment Treatment for Bipolar Disorder [Phase 4]
Phase 4 clinical trial update on sequential multiple assignment treatment for bipolar disorder (bipolar I and II) completed with results pos…
-
FDA approval · 2019-12-20FDA Approved: QUETIAPINE FUMARATE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for quetiapine fumarate from Aurobindo Pharma Limited, allowing continued marketing of this generic …
-
CLINICAL_TRIALS trial_result · 2019-01-25Clinical Trial Update: Efficacy and Tolerability Study of Betahistine to Ameliorate Antipsychotic Associated Weight Gain [Phase 2]
Phase 2 trial evaluating betahistine for efficacy and tolerability in reducing antipsychotic-associated weight gain; the study is completed …
-
FDA approval · 2018-12-20FDA Approved: LITHIUM CARBONATE — Supplemental Application (Rising Pharma Holdings, Inc.)
The FDA approved a supplemental application for lithium carbonate filed by Rising Pharma Holdings, Inc., indicating an approved modification…
-
CLINICAL_TRIALS withdrawal · 2018-07-20Clinical Trial Update: Open-Label Study of Latuda for the Treatment of Mania in Children and Adolescents 6-17 Years Old [Phase 4]
Open-label Phase 4 study of lurasidone (Latuda) for mania in youths aged 6-17 was withdrawn.